Why Do Parents Need Karyotype Testing After Trisomy 18?
At a Glance
Parents are offered karyotype testing after a baby has partial or translocation trisomy 18 to find out whether either parent carries a balanced chromosome rearrangement. The results help estimate recurrence risk and guide future pregnancy testing and choices.
When a baby is diagnosed with partial trisomy 18 (having extra material from only part of chromosome 18) or translocation trisomy 18 (where the extra chromosome 18 material is attached to a different chromosome), doctors usually recommend a blood test called a karyotype for both biological parents [1]. A karyotype examines the number and large-scale structure of your chromosomes [1]. Finding out whether the baby’s chromosomal change was inherited or happened entirely by chance helps your medical team provide accurate information about the chances of it happening again in future pregnancies.
It Is Not Your Fault
Being offered this test can sometimes feel like an accusation, especially when you are completely healthy. It is crucial to understand that no one does anything to cause a chromosome rearrangement. They happen naturally and are completely out of our control. If testing shows you do carry a translocation, it does not mean you are “at fault” or that you did something to cause your baby’s diagnosis.
What Is a Balanced Translocation?
Chromosomes are like instruction manuals for the body. A balanced translocation means that pieces of two different chromosomes broke off and traded places [2]. Because usually no large amount of DNA is lost or gained, a parent with a balanced translocation still has all the right genetic instructions—just in a different order [2]. As a result, carriers are usually healthy and have no symptoms [2].
However, when a parent’s body makes egg or sperm cells, chromosomes have to divide. Sometimes they divide unevenly. If an egg or sperm gets an “unbalanced” set of chromosomes, the baby might inherit an extra piece of chromosome 18 [2]. The exact clinical impact on the baby depends on the specific duplicated and deleted chromosome segments involved [2].
How Your Results Affect the Future
After reviewing the baby’s full chromosome report, testing both parents helps map out what to expect for the future:
- If both parents have normal karyotypes: A normal result usually suggests the baby’s rearrangement was de novo (a new change that arose randomly in the egg, sperm, or early embryo) [3]. The chances of having another baby with trisomy 18 are generally low [3]. However, a normal blood karyotype cannot completely rule out very small, cryptic changes or mosaicism (where the change only exists in certain cells, like the reproductive organs), so your genetic counselor will still calculate an individualized recurrence estimate [3].
- If a parent carries a balanced translocation: Your recurrence risk is higher. A genetics professional will review the exact chromosomes involved and provide a specific recurrence risk for your family [2].
Future Family Planning Options
If you are at an increased risk, genetic counseling can help you explore several reproductive choices. Reproductive decisions are deeply personal, and there is no single “right” choice. Options include natural conception, adoption, or using donor gametes. If you choose to pursue a biological pregnancy, options include:
- Diagnostic Prenatal Testing: If you conceive naturally, you can choose to have chorionic villus sampling (CVS) (usually performed around 10 weeks) or amniocentesis (usually from 15 weeks) [4]. These are diagnostic procedures that can establish the baby’s chromosome complement [4]. However, CVS occasionally reflects confined placental mosaicism, and neither test rules out every possible genetic condition [4].
- Preimplantation Genetic Testing for Structural Rearrangements (PGT-SR): This involves in vitro fertilization (IVF) to test embryos for the specific structural rearrangement before pregnancy [2]. PGT-SR requires IVF, has significant costs, may not produce a transferable embryo, and is generally followed by diagnostic testing during pregnancy [2].
- Non-Invasive Prenatal Testing (NIPT): Standard NIPT is a maternal blood test that screens for whole-chromosome extra copies [5]. If there is a known familial rearrangement, standard NIPT may not reliably detect the specific partial duplication or translocation and should not be used as a substitute for diagnostic testing [5].
Common questions in this guide
Why are both biological parents offered karyotype testing after a baby has translocation trisomy 18?
Can a healthy parent have a balanced translocation?
What does a normal karyotype in both parents mean for another pregnancy?
What if one parent is found to carry a balanced translocation?
Which tests can check a baby's chromosomes in a future pregnancy?
Can standard NIPT detect a familial translocation involving chromosome 18?
Related questions
Show more
Get notified when new evidence is published on Trisomy 18 syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (5)
- 1
Prenatal Diagnosis of Cleft Lip and Palate: A Retrospective Study.
Brăila AD, Damian CM, Albu CC, et al.
Journal of clinical medicine 2024; (13(16)) doi:10.3390/jcm13164804.
PMID: 39200946 - 2
A Case of a Derivative Chromosome: der(Y)t(Y;18)Pat with Congenital Abnormalities.
Huang S, Xia Y, Ding H, et al.
Fetal and pediatric pathology 2021; (40(3)):256-261 doi:10.1080/15513815.2019.1695297.
PMID: 31805817 - 3
Prenatal diagnosis and molecular genetic analysis of recurrent trisomy 18 of maternal origin in two consecutive pregnancies.
Chen CP, Wu FT, Wong CH, et al.
Taiwanese journal of obstetrics & gynecology 2023; (62(3)):444-447 doi:10.1016/j.tjog.2023.03.006.
PMID: 37188451 - 4
Detection of paternal origin of fetal trisomy 18 in a pregnancy conceived by assisted reproductive technology and in vitro fertilization.
Chen CP, Chern SR, Wang LK, et al.
Taiwanese journal of obstetrics & gynecology 2020; (59(4)):607-609 doi:10.1016/j.tjog.2020.05.024.
PMID: 32653139 - 5
The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis.
Mackie FL, Hemming K, Allen S, et al.
BJOG : an international journal of obstetrics and gynaecology 2017; (124(1)):32-46 doi:10.1111/1471-0528.14050.
PMID: 27245374
This page explains why parental karyotype testing may be recommended after partial or translocation trisomy 18; it is for informational purposes only and does not replace advice from a genetic counselor or other healthcare professional.